ClinicalTrials.Veeva

Menu

Parent Therapist Partnership to Provide Early, Intensive Exercise in Perinatal Stroke

U

University of Alberta

Status

Active, not recruiting

Conditions

Perinatal Stroke

Treatments

Behavioral: Intensive exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT03672864
Pro00078553

Details and patient eligibility

About

A prospective, single blind, parallel group, randomized control trial to determine if early, intensive lower extremity activity delivered by a physical therapist and a parent in partnership improves gross motor function more than usual care.

Full description

A mixed-methods randomized controlled trial at 3 healthcare centres: Edmonton, Calgary and Ottawa. The period of participation for each child is 12 months. The Immediate Group will have 3 months of intervention and 9 months follow-up. The Delay Group will be followed for 6 months (waitlist-control period), then given the opportunity to receive the same intervention and followed for 3 months after the intervention.

The intervention will be delivered by clinicians in the rehabilitation centres in partnership with the child's parents. Therapists will provide training 2 days a week and will coach the parents to provide the training at home for 2 days a week.

The intervention is ELEVATE (Engaging the Lower Extremity Via Active Therapy Early) and consists of child-initiated, intensive leg activities for one hour a day, four days a week for 12 weeks.

Enrollment

18 patients

Sex

All

Ages

8 to 36 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • children ages 8 months to 3 years
  • medical history and physical exam consistent with perinatal stroke
  • hemiparesis in the upper and/or lower extremity
  • parental agreement to adhere to the training and testing schedule

Exclusion criteria

  • bilateral motor impairment
  • epileptic seizures that could interfere with training
  • cognitive, behavioural or developmental impairments that preclude participation in the protocol
  • botulinum toxin A injections or surgery in the lower extremities within the previous six months
  • concurrent casting during the intervention phase (including constraint-induced movement therapy with casting)
  • diagnosis associated with neurological/developmental regression
  • parent unable to communicate (verbal and written) in English or French

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

18 participants in 2 patient groups

Immediate Group
Experimental group
Description:
The intervention is intensive exercise, delivered over 12 weeks beginning on admission to the study. The group will then be followed for 9 months post intervention.
Treatment:
Behavioral: Intensive exercise
Delay Group
No Intervention group
Description:
The group will be followed for 6 months with no intervention. After 6 months the group will be given the opportunity to receive the same intensive exercise intervention as the Immediate group. The group will be followed for 3 months following the intervention.

Trial contacts and locations

3

Loading...

Central trial contact

Michelle Barnes; Jaynie Yang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems